Craneware Stock

Craneware ROE

Delisted·Jun 19, 2026

The Return on Equity (ROE) of Craneware (CRW.L) as of Aug 10, 2026 is 5.83 %. In the previous year, Return on Equity (ROE) was 3.56 % — a change of 63.55% (higher).

ROE

5.83 %

YoY

63.55%

Last updated:

In 2026, Craneware's return on equity (ROE) was 5.83 %, a 63.55% increase from the 3.56 % ROE in the previous year.

Access this data via the Eulerpool API

Craneware Stock analysis

What does Craneware do? Craneware PLC is a publicly traded company based in Edinburgh, Scotland, that specializes in the development and marketing of software solutions for the healthcare industry. The company was founded in 1999 and has been listed on the London Stock Exchange since 2007. The business model of Craneware is based on the development and marketing of software solutions for the healthcare industry that help customers optimize their financial and performance processes. Craneware focuses particularly on the area of Revenue Cycle Management (RCM), which involves the management of hospital billing and payment processes. Craneware's software solutions are used in various areas, including billing, pricing, contract management, compliance, and analytics. The products are modular and can be individually configured according to the customer's needs. One example of a product is the Revenue Integrity Management System (RIMS), which allows for comprehensive analysis of patient billing and ensures that hospitals maximize their revenue while complying with regulations. Other products include Reference Plus, which helps customers determine and stay competitive with pricing for medical services, and the Online Analytics Suite, which specializes in data analysis and reporting. Craneware is divided into different divisions, including North America, International, and UK & EMEA. North America is the largest market for the company, accounting for approximately 90% of its revenue. In North America, Craneware has a strong presence and works closely with many large hospitals and healthcare organizations. The company's focus on RCM solutions has received significant attention, and many customers appreciate the efficiency and effectiveness of the software solutions. In the International division, Craneware focuses on expanding its presence in Europe, Asia, Africa, and the Middle East. The company has already gained many partners in these regions and is working to further expand its market share. In the UK & EMEA division, Craneware primarily serves NHS hospitals (National Health Service) and offers a wide range of RCM solutions to its customers. Craneware was founded in 1999 by Edinburgh University graduate Gordon Craig. The company's headquarters were established in Edinburgh and quickly became a major employer in the city. In 2007, Craneware was listed on the London Stock Exchange and has since been a publicly traded company. In 2015, the company was included in the FTSE AIM 100 Index. In recent years, Craneware has experienced strong growth and expanded its market presence to different countries. The company plans to continue investing in research and development and focusing on innovation to provide its customers with the best RCM solutions in the future. Craneware is one of the most popular companies on Eulerpool.

ROE Details

Decoding Craneware's Return on Equity (ROE)

Craneware's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Craneware's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Craneware's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Craneware’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Craneware stock

Return on Equity (ROE) of Craneware is 5.83 % in 2026.

Return on Equity (ROE) of Craneware changed from 3.56 % to 5.83 %, representing a 63.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Craneware since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Craneware with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — Craneware

All Key Metrics — Craneware